Nivolumab plus platinum-doublet chemotherapy as first-line therapy in unresectable, locally advanced or metastatic G3 neuroendocrine Neoplasms (NENs) of the gastroenteropancreatic (GEP) tract or unknown (UK) origin: Preliminary results from the phase II NICE-NEC trial (GETNE T1913)

dc.conference.dateSEP 16-21, 2021
dc.conference.titleCongress of the European-Society-for-Medical-Oncology (ESMO)
dc.contributor.authorRiesco-Martinez, M. C.
dc.contributor.authorCapdevila, J.
dc.contributor.authorAlonso, V.
dc.contributor.authorJimenez-Fonseca, P.
dc.contributor.authorTeule, A.
dc.contributor.authorGrande, E.
dc.contributor.authorSevilla, I.
dc.contributor.authorBenavent Vinuales, M.
dc.contributor.authorAlonso-Gordoa, T.
dc.contributor.authorCustodio, A.
dc.contributor.authorHernando, J.
dc.contributor.authorPolo, E.
dc.contributor.authorCastillo Trujillo, O. A.
dc.contributor.authorGarcia-Carbonero, R.
dc.contributor.authoraffiliation[Riesco-Martinez, M. C.] Hosp Univ 12 Octubre, Dept Med Oncol, UCM, Imas12, Madrid, Spain
dc.contributor.authoraffiliation[Garcia-Carbonero, R.] Hosp Univ 12 Octubre, Dept Med Oncol, UCM, Imas12, Madrid, Spain
dc.contributor.authoraffiliation[Capdevila, J.] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Hernando, J.] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Alonso, V.] Hosp Univ Miguel Servet, Inst Aragones Invest Sanitaria, Med Oncol Dept, Zaragoza, Spain
dc.contributor.authoraffiliation[Polo, E.] Hosp Univ Miguel Servet, Inst Aragones Invest Sanitaria, Med Oncol Dept, Zaragoza, Spain
dc.contributor.authoraffiliation[Jimenez-Fonseca, P.] Hosp Univ Cent Asturias, Med Oncol Dept, ISPA, Oviedo, Spain
dc.contributor.authoraffiliation[Castillo Trujillo, O. A.] Hosp Univ Cent Asturias, Med Oncol Dept, ISPA, Oviedo, Spain
dc.contributor.authoraffiliation[Teule, A.] Inst Catala Oncol ICO IDIBELL, Med Oncol Dept, Lhospitalet De Llobregat, Spain
dc.contributor.authoraffiliation[Grande, E.] MD Anderson Canc Ctr Madrid, Dept Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Sevilla, I.] Hosp Univ Reg & Virgen Victoria Malaga, Inst Invest Biomed Malaga IBIMA, Invest Clin & Traslac Canc, Med Oncol Dept, Malaga, Spain
dc.contributor.authoraffiliation[Benavent Vinuales, M.] Univ Hosp Virgen Rocio, Inst Biomed Sevilla IBIS, Med Oncol Dept, Seville, Spain
dc.contributor.authoraffiliation[Alonso-Gordoa, T.] Hosp Univ Ramon & Cajal, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Custodio, A.] Hosp Univ La Paz, Med Oncol Dept, Madrid, Spain
dc.contributor.funderBristol Myers Squibb (BMS)
dc.date.accessioned2025-01-07T15:18:03Z
dc.date.available2025-01-07T15:18:03Z
dc.date.issued2021-09-21
dc.identifier.doi10.1016/j.annonc.2021.08.180
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.annonc.2021.08.180
dc.identifier.urihttps://hdl.handle.net/10668/27026
dc.identifier.wosID700527702116
dc.issue.number5
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen de la Victoria
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.organizationInstituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
dc.organizationInstituto de Investigación Biomédica de Sevilla (IBIS)
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.page.numberS908-S909
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleNivolumab plus platinum-doublet chemotherapy as first-line therapy in unresectable, locally advanced or metastatic G3 neuroendocrine Neoplasms (NENs) of the gastroenteropancreatic (GEP) tract or unknown (UK) origin: Preliminary results from the phase II NICE-NEC trial (GETNE T1913)
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files